INS and metabolic dysfunction-associated steatotic liver disease: It has been found that NAFLD is characterized by clinical and laboratory data that is similar to diabetes and obesity; for example, it has been characterized by impaired insulin sensitivity and abnormalities in lipid metabolism, even in the presence of normoglycaemia and normal or moderately increased body weight [12].